FIND, DNDi to sup­port Malaysian MoH for ap­proach­ing HCV

BioSpectrum (Asia) - - Regulatory News -

The Foun­da­tion for In­no­va­tive New Di­ag­nos­tics (FIND) and the Drugs for Ne­glected Dis­eases ini­tia­tive (DNDi) will part­ner to gen­er­ate ev­i­dence that will sup­port pol­icy change and scale up of hep­ati­tis C (HCV) di­ag­no­sis and treat­ment. This work, an­nounced at the AIDS 2018 con­fer­ence in Amsterdam and ahead of World Hep­ati­tis Day 2018, is be­ing con­ducted in col­lab­o­ra­tion with the Min­istry of Health (MoH) in Malaysia with a view to over­com­ing bar­ri­ers to di­ag­no­sis and treat­ment. It forms part of a larger FIND project known as Hep­ati­tis C Elim­i­na­tion through Ac­cess to Di­ag­nos­tics (HEAD-Start), sup­ported by Uni­taid. Although the World Health Or­ga­ni­za­tion (WHO) has pre­qual­i­fied dif­fer­ent types of HCV tests, screen­ing and con­fir­ma­tory di­ag­no­sis of hep­ati­tis C are not widely avail­able, and re­main largely cen­tral­ized and siloed where they do ex­ist. This means that iden­ti­fy­ing those with the disease so they can be linked to care is a huge chal­lenge. FIND will demon­strate the fea­si­bil­ity of us­ing rapid di­ag­nos­tic tests (RDTs) in de­cen­tral­ized pri­mary health­care fa­cil­i­ties, and pro­vide tech­ni­cal as­sis­tance to the Min­istry of Health in Malaysia to sup­port the project.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.